150 related articles for article (PubMed ID: 16287259)
41. Low-density lipoprotein specifically binds glycoprotein IIb/IIIa: a flow cytometric method for ligand-receptor interaction.
Tetik S; Uras F; Ekşioğlu-Demiralp E; Turay Yardimci K
Clin Appl Thromb Hemost; 2008 Apr; 14(2):210-9. PubMed ID: 18160616
[TBL] [Abstract][Full Text] [Related]
42. Effects of platelet glycoprotein IIb-IIIa number and glycoprotein IIIa Leu33Pro polymorphism on platelet aggregation and sensitivity to glycoprotein IIb-IIIa antagonists.
Sirotkina OV; Khaspekova SG; Zabotina AM; Shimanova YV; Mazurov AV
Platelets; 2007 Nov; 18(7):506-14. PubMed ID: 17957566
[TBL] [Abstract][Full Text] [Related]
43. Synthesis and application of poly(ethylene glycol)-cholesterol (Chol-PEGm) conjugates in physicochemical characterization of nonionic surfactant vesicles.
Yang DB; Zhu JB; Huang ZJ; Ren HX; Zheng ZJ
Colloids Surf B Biointerfaces; 2008 Jun; 63(2):192-9. PubMed ID: 18295461
[TBL] [Abstract][Full Text] [Related]
44. Fibrinogen-conjugated albumin polymers and their interaction with platelets under flow conditions.
Takeoka S; Teramura Y; Okamura Y; Handa M; Ikeda Y; Tsuchida E
Biomacromolecules; 2001; 2(4):1192-7. PubMed ID: 11777392
[TBL] [Abstract][Full Text] [Related]
45. In-vitro efficacy of different platelet glycoprotein IIb/IIIa antagonists and thrombolytics on platelet/fibrin-mediated clot dynamics in human whole blood using thrombelastography.
Mousa SA
Blood Coagul Fibrinolysis; 2007 Jan; 18(1):55-60. PubMed ID: 17179828
[TBL] [Abstract][Full Text] [Related]
46. Effect of curcumin on the adhesion of platelets to brain microvascular endothelial cells in vitro.
Zhang L; Gu ZL; Qin ZH; Liang ZQ
Acta Pharmacol Sin; 2008 Jul; 29(7):800-7. PubMed ID: 18565277
[TBL] [Abstract][Full Text] [Related]
47. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
[TBL] [Abstract][Full Text] [Related]
48. Activated Platelet-Derived Vesicles for Efficient Hemostatic Activity.
Lee JH; Jung H; Song J; Choi ES; You G; Mok H
Macromol Biosci; 2020 Mar; 20(3):e1900338. PubMed ID: 32053289
[TBL] [Abstract][Full Text] [Related]
49. Fibrinogen gamma' chain carboxy terminal peptide selectively inhibits the intrinsic coagulation pathway.
Lovely RS; Boshkov LK; Marzec UM; Hanson SR; Farrell DH
Br J Haematol; 2007 Nov; 139(3):494-503. PubMed ID: 17910639
[TBL] [Abstract][Full Text] [Related]
50. Platelet membrane vesicles reduced microvascular bleeding times in thrombocytopenic rabbits.
McGill M; Fugman DA; Vittorio N; Darrow C
J Lab Clin Med; 1987 Feb; 109(2):127-33. PubMed ID: 3805864
[TBL] [Abstract][Full Text] [Related]
51. Reassociation and translocation of glycoprotein IIB-IIIA in EDTA-treated human platelets.
Ma Y; Wong K
Platelets; 2007 Sep; 18(6):451-9. PubMed ID: 17763154
[TBL] [Abstract][Full Text] [Related]
52. Effects of escalating doses of tirofiban on platelet aggregation and major receptor expression in diabetic patients: hitting the TARGET in the TENACITY trial?
Serebruany V; Malinin A; Pokov A; Arora U; Atar D; Angiolillo D
Thromb Res; 2007; 119(2):175-81. PubMed ID: 16546241
[TBL] [Abstract][Full Text] [Related]
53. In vitro characterization of SynthoPlate™ (synthetic platelet) technology and its in vivo evaluation in severely thrombocytopenic mice.
Shukla M; Sekhon UD; Betapudi V; Li W; Hickman DA; Pawlowski CL; Dyer MR; Neal MD; McCrae KR; Sen Gupta A
J Thromb Haemost; 2017 Feb; 15(2):375-387. PubMed ID: 27925685
[TBL] [Abstract][Full Text] [Related]
54. Elevated fibrinogen fragment levels in uremic plasma inhibit platelet function and expression of glycoprotein IIb-IIIa.
Thekkedath UR; Chirananthavat T; Leypoldt JK; Cheung AK; Mohammad SF
Am J Hematol; 2006 Dec; 81(12):915-26. PubMed ID: 16917914
[TBL] [Abstract][Full Text] [Related]
55. Relationship between changes in platelet reactivity and changes in platelet receptor expression induced by physical exercise.
Aurigemma C; Fattorossi A; Sestito A; Sgueglia GA; Farnetti S; Buzzonetti A; Infusino F; Landolfi R; Scambia G; Crea F; Lanza GA
Thromb Res; 2007; 120(6):901-9. PubMed ID: 17337041
[TBL] [Abstract][Full Text] [Related]
56. Antiplatelet and antithrombotic activity of indole-3-carbinol in vitro and in vivo.
Park MK; Rhee YH; Lee HJ; Lee EO; Kim KH; Park MJ; Jeon BH; Shim BS; Jung CH; Choi SH; Ahn KS; Kim SH
Phytother Res; 2008 Jan; 22(1):58-64. PubMed ID: 17724769
[TBL] [Abstract][Full Text] [Related]
57. Selective uptake of surface-modified phospholipid vesicles by bone marrow macrophages in vivo.
Sou K; Goins B; Takeoka S; Tsuchida E; Phillips WT
Biomaterials; 2007 Jun; 28(16):2655-66. PubMed ID: 17316790
[TBL] [Abstract][Full Text] [Related]
58. Fibrinogen-coated albumin microcapsules reduce bleeding in severely thrombocytopenic rabbits.
Levi M; Friederich PW; Middleton S; de Groot PG; Wu YP; Harris R; Biemond BJ; Heijnen HF; Levin J; ten Cate JW
Nat Med; 1999 Jan; 5(1):107-11. PubMed ID: 9883848
[TBL] [Abstract][Full Text] [Related]
59. Characterizing the modification of surface proteins with poly(ethylene glycol) to interrupt platelet adhesion.
Xu H; Kaar JL; Russell AJ; Wagner WR
Biomaterials; 2006 Jun; 27(16):3125-35. PubMed ID: 16457880
[TBL] [Abstract][Full Text] [Related]
60. Possible hemostatic effect of synthetic liposomes in experimental studies under flow conditions.
Galán AM; Casals E; Estelrich J; Hernández MR; Bozzo J; Reverter J; Mazzara R; Ordinas A; Escolara G
Haematologica; 2002 Jun; 87(6):615-23. PubMed ID: 12031918
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
